首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1547367

全球人类微生物组市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Human Microbiome Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球人类微生物组市场需求预计将从 2023 年的 22.6 亿美元达到 2032 年近 44.2 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 7.72%。

人类微生物组包含存在于人体内部和表面的多种微生物群落，例如细菌、真菌、病毒和其他微生物。这些微生物对于维持健康、帮助消化、合成维生素和防御病原体至关重要。微生物群最集中在肠道中，但也集中在皮肤、口腔和其他黏膜表面。微生物组失衡与各种健康问题有关，例如肥胖、糖尿病、发炎性肠道疾病和精神健康障碍。

市场动态

人们越来越认识到微生物组在健康和疾病中的关键作用，激发了人们对微生物组研究和治疗的兴趣。定序技术和生物资讯学的进步促进了更详细和更全面的人类微生物组分析，带来新的见解和潜在的治疗标靶。胃肠道疾病、代谢疾病和自体免疫疾病等慢性疾病的流行，凸显了调节微生物组的创新疗法的必要性。此外，个人化医疗的不断增长趋势正在推动市场成长，其中针对个人独特的微生物组特征量身定制干预措施。

监管机构越来越认识到微生物干预的潜力，为临床试验和产品审批提供支持性环境。此外，消费者对益生菌和益生元作为健康生活方式一部分的兴趣日益浓厚，也推动了对微生物组相关产品的需求。学术界、工业界和医疗保健提供者之间的合作正在促进创新并扩大人类微生物组研究的应用。然而，微生物组的复杂性、监管挑战以及需要更全面的研究以充分了解其相互作用和影响，可能会阻碍未来几年人类微生物组市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球人类微生物组市场的每个细分市场进行了包容性评估。人类微生物组市场产业的成长和趋势为本研究提供了整体方法。

市场区隔

人类微生物组市场市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按指示

胃肠道和代谢紊乱
女性健康
癌症
其他的

依技术

16s rRNA 定序
宏基因体定序

按治疗领域

胃肠道疾病
代谢紊乱
女性健康
皮肤病
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲人类微生物组市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。人类微生物组市场的主要参与者包括 AOBiome、Enterome Biosciences SA、Metabiomics Corp. (BioSpherex LLC)、Microbiome Therapeutics LLC、Osel Inc.、Second Genome、Seres Therapeutics、Synthetic Biologics Inc.、Vedanta Biosciences、4DD、Seres Therapeutics、Synthetic Biologics Inc.、Vedanta Biosciences、4DD Pharma、Ferrceuticals Pharmas 。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：人类微生物组市场公司的竞争格局

人类微生物组市场市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
AOBiome

公司概况
公司收入
产品
最新动态

Enterome Biosciences SA

公司概况
公司收入
产品
最新动态

Metabiomics Corp. (BioSpherex LLC)

公司概况
公司收入
产品
最新动态

Microbiome Therapeutics LLC

公司概况
公司收入
产品
最新动态

Osel Inc.

公司概况
公司收入
产品
最新动态

Second Genome

公司概况
公司收入
产品
最新动态

Seres Therapeutics

公司概况
公司收入
产品
最新动态

Synthetic Biologics Inc.

公司概况
公司收入
产品
最新动态

Vedanta Biosciences

公司概况
公司收入
产品
最新动态

4D Pharma

公司概况
公司收入
产品
最新动态

Ferring Pharmaceuticals

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11215790

The global demand for Human Microbiome Market is presumed to reach the market size of nearly USD 4.42 Billion by 2032 from USD 2.26 Billion in 2023 with a CAGR of 7.72% under the study period 2024-2032.

The human microbiome encompasses a diverse community of microorganisms, such as bacteria, fungi, viruses, and other microbes, residing within and on the human body. These microorganisms are essential in maintaining health, aiding digestion, synthesizing vitamins, and protecting against pathogens. The microbiome is most concentrated in the gut but also on the skin, mouth, and other mucosal surfaces. Imbalances in the microbiome are linked to various health issues, such as obesity, diabetes, inflammatory bowel disease, and mental health disorders.

MARKET DYNAMICS

The increasing awareness of the microbiome's crucial role in health and disease has spurred interest in microbiome research and therapeutics. Advances in sequencing technologies and bioinformatics have facilitated more detailed and comprehensive human microbiome analysis, leading to new insights and potential therapeutic targets. The spurring prevalence of chronic diseases, such as gastrointestinal disorders, metabolic conditions, and autoimmune diseases, has highlighted the need for innovative treatments to modulate the microbiome. Additionally, the growing trend towards personalized medicine, where interventions are tailored to the individual's unique microbiome profile, is propelling market growth.

Regulatory agencies increasingly recognize the potential of microbiome interventions, providing a supportive environment for clinical trials and product approvals. Moreover, increasing consumer interest in probiotics and prebiotics as part of a healthy lifestyle drives demand for microbiome-related products. Collaborative efforts between academia, industry, and healthcare providers are fostering innovation and expanding the applications of human microbiome research. However, the complexity of the microbiome, regulatory challenges, and the need for a more comprehensive study to fully understand its interactions and effects may hinder the growth of the human microbiome market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Human Microbiome Market. The growth and trends of Human Microbiome Market industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Human Microbiome Market market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indication

Gastrointestinal & Metabolic Disorders
Women's Health
Cancer
Others

By Technology

16s rRNA Sequencing
Metagenomic Sequencing

By Therapeutic Area

Gastrointestinal Disorders
Metabolic Disorders
Women's Health
Skin Disorders
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Human Microbiome Market market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Human Microbiome market include AOBiome, Enterome Biosciences SA, Metabiomics Corp. (BioSpherex LLC), Microbiome Therapeutics LLC, Osel Inc., Second Genome, Seres Therapeutics, Synthetic Biologics Inc., Vedanta Biosciences, 4D Pharma, Ferring Pharmaceuticals. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. HUMAN MICROBIOME MARKET - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Indication
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Therapeutic Area
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY INDICATION

5.1. Overview By Indication
5.2. Historical and Forecast Data Analysis By Indication
5.3. Gastrointestinal & Metabolic Disorders Historic and Forecast Sales By Regions
5.4. Women's Health Historic and Forecast Sales By Regions
5.5. Cancer Historic and Forecast Sales By Regions
5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data Analysis By Technology
6.3. 16s rRNA Sequencing Historic and Forecast Sales By Regions
6.4. Metagenomic Sequencing Historic and Forecast Sales By Regions

7. GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY THERAPEUTIC AREA

7.1. Overview By Therapeutic Area
7.2. Historical and Forecast Data Analysis By Therapeutic Area
7.3. Gastrointestinal Disorders Historic and Forecast Sales By Regions
7.4. Metabolic Disorders Historic and Forecast Sales By Regions
7.5. Women's Health Historic and Forecast Sales By Regions
7.6. Skin Disorders Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HUMAN MICROBIOME MARKET COMPANIES

9.1. Human Microbiome Market Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF HUMAN MICROBIOME MARKET INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. AOBiome
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Enterome Biosciences SA
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Metabiomics Corp. (BioSpherex LLC)
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Microbiome Therapeutics LLC
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Osel Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Second Genome
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Seres Therapeutics
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Synthetic Biologics Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Vedanta Biosciences
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. 4D Pharma
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Ferring Pharmaceuticals
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments